• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脑血管疾病与含孕二烯酮口服避孕药的使用——因果关系还是巧合?]

[Cerebrovascular disorders and administration of oral contraceptives containing gestodene--causal relation or coincidence?].

作者信息

König H J, Anagnostopoulos-Schleep J, Mewe R

机构信息

Klinik und Poliklinik für Neurochirugie der Westfäilschen Wilhelms-Universität Münster.

出版信息

Med Klin (Munich). 1991 Jul 15;86(7):333-7, 382.

PMID:1921893
Abstract

During the last two years oral contraceptives containing gestodene were suspected to cause cerebrovascular disorders. 52 cases with adverse neurological side effects were registered up to October 31, 1990. Anonymous protocols received from the Companies Schering AG and Wyeth Pharma were analyzed from a clinical point of view. There are different arterial and venous, thrombotic and embolic disorders caused by different pathogenetic principles. Only one third of the cases was documented by neuro-imaging to render possible actual diagnostic reliability. Suspected cases represent a great number of different cerebrovascular disorders usually observed in neurological and neurosurgical series, concerning both men and women, OC-users and non users.

摘要

在过去两年中,含孕二烯酮的口服避孕药被怀疑会引发脑血管疾病。截至1990年10月31日,共记录了52例有不良神经副作用的病例。从临床角度对先灵公司和惠氏制药公司提供的匿名记录进行了分析。不同的发病机制导致了不同的动静脉、血栓形成和栓塞性疾病。只有三分之一的病例有神经影像学记录,以确保实际诊断的可靠性。疑似病例代表了大量通常在神经科和神经外科病例中观察到的不同脑血管疾病,涉及男性和女性、口服避孕药使用者和非使用者。

相似文献

1
[Cerebrovascular disorders and administration of oral contraceptives containing gestodene--causal relation or coincidence?].[脑血管疾病与含孕二烯酮口服避孕药的使用——因果关系还是巧合?]
Med Klin (Munich). 1991 Jul 15;86(7):333-7, 382.
2
Effects of two oral contraceptives, containing 30 or 20 microg of ethinyl estradiol in combination with gestodene, on blood coagulation and fibrinolysis in Brazilian women.两种口服避孕药(分别含30微克或20微克炔雌醇与孕二烯酮组合)对巴西女性血液凝固和纤维蛋白溶解的影响。
Int J Fertil Womens Med. 2001 Sep-Oct;46(5):265-70.
3
Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.口服避孕药使用期间活化因子VII水平升高,血浆蛋白S活性降低,循环血栓调节蛋白减少。
Thromb Haemost. 1996 Nov;76(5):729-34.
4
[Clinical study of a low-dose contraceptive--Femodene].一种低剂量避孕药——妈富隆的临床研究
Akush Ginekol (Sofiia). 1995;34(3):71-3.
5
Clinical experience in Switzerland with the new monophasic oral contraceptive Minulet (75 mcg gestodene, 30 mcg ethinyl oestradiol).瑞士使用新型单相口服避孕药敏定偶(孕二烯酮75微克,炔雌醇30微克)的临床经验。
Br J Clin Pract. 1988 Jul;42(7):292-8.
6
[Our experience with the use of the contraceptive preparations Femovan and Triquilar from the Schering firm].
Akush Ginekol (Sofiia). 1992;31(2):42-3.
7
[Clinical experiences with femovan (Gynera)].[非那雄胺(保法止)的临床经验]
Ther Umsch. 1990 Dec;47(12):958-65.
8
[Clinical experiences with a gestodene containing oral contraceptive (femoden)].[含孕二烯酮口服避孕药(敏定偶)的临床经验]
Acta Pharm Hung. 1998 Sep;68(5):289-93.
9
[Acceptability and secondary effects of a new oral contraceptive containing ethinylestradiol and gestodene].[一种含炔雌醇和孕二烯酮的新型口服避孕药的可接受性及副作用]
Rev Med Brux. 1987 Nov;8(9):440-6.
10
[Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].[低剂量口服避孕药的个体化。口服避孕药的药理学原理及实际应用指征]
Minerva Ginecol. 2007 Aug;59(4):415-25.

引用本文的文献

1
Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.孕二烯酮。关于其在复方避孕制剂中的药理学、疗效及耐受性的综述。
Drugs. 1995 Aug;50(2):364-95. doi: 10.2165/00003495-199550020-00010.